Cicatricial pemphigoid.
Foster
C S
CS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D003228:Conjunctiva / Q000473:pathology / Q000648:ultrastructure; D003231:Conjunctivitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005260:Female; D006651:Histocytochemistry; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049690:History, Ancient; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D037102:Lectins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009093:Mucus / Q000032:analysis; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy / Q000266:history / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011897:Random Allocation; D012872:Skin Diseases, Vesiculobullous / Q000266:history / Q000473:pathology / Q000503:physiopathology; D013601:T-Lymphocytes / Q000145:classification; D013666:Tears / Q000502:physiology
D007166:Immunosuppressive Agents; D037102:Lectins